Shareholders Suffering Losses Given Chance to Lead Schall Law Firm’s Securities Class Actions

Class Action Lawsuit Filed Against Applied Therapeutics, Inc.: What Does It Mean for Investors and the World? On February 3, 2025, The Schall Law Firm announced that it had filed a class action lawsuit against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT) in the United States District Court for the Central District…

Read More

Eutelsat Shares Take a Dip: Investors Pause Amid Uncertainty Surrounding Ukraine Prospects (Reuters Tech, March 7, 2025)

Eutelsat Shares Surge on Ukraine’s Potential Switch from Starlink Franco-British satellite operator Eutelsat’s shares experienced a significant pullback on Friday, following a nearly 500% surge earlier in the week. The sudden increase in value was primarily driven by speculation that Ukraine might switch from SpaceX’s Starlink satellite internet service to Eutelsat’s offerings. Background: Starlink’s Dominance…

Read More

Bronstein, Gewirtz & Grossman, LLC: Encouraging Shareholder Action Against Dominion Energy, Inc. (D)

Investigation into Dominion Energy Securities: What Does It Mean for Investors and the World? On February 19, 2025, Bronstein, Gewirtz & Grossman, LLC, a prominent securities litigation firm, announced that it is investigating potential claims on behalf of purchasers of Dominion Energy, Inc. (Dominion or the Company) regarding alleged securities law violations. The investigation comes…

Read More

Breaking News: Rain Oncology to be Acquired by Pathos AI for $1.16 Per Share, Plus Contingent Value Rights!

Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights Newark, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) Rain Oncology Inc. (Nasdaq: RAIN) (“Rain”), today announced it has entered into a definitive merger agreement whereby Pathos AI, Inc. (“Pathos”) will acquire Rain for $1.16 in…

Read More

“Attention Investors: Don’t Miss Out on the Cardlytics Inc. Class Action! A Friendly Reminder from Robbins LLP”

Hey there, fellow investors! Did you catch the latest buzz about Cardlytics, Inc. (NASDAQ: CDLX)? Robbins LLP wants to make sure you’re in the loop about a recent class action filed on behalf of investors who purchased or acquired Cardlytics securities between March 14, 2024, and August 7, 2024. In case you’re not familiar, Cardlytics…

Read More